Schizophrenia: all 3,539 studies
Page 36 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Broad Effectiveness: Study With AripiprazoleCompletedNCT00036361Phase 3
- Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic DisordersCompletedNCT00036127Phase 2/3
- Olanzapine Versus An Active Comparator in the Treatment of SchizophreniaCompletedNCT00036088Phase 4
- A Comparison of Seroquel vs. Risperidone in SchizophreniaCompletedNCT00034905Phase 4
- CAFE Comparison of Atypicals in First Episode of PsychosisCompletedNCT00034892Phase 3
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With SchizophreniaCompletedNCT00034801Phase 4
- A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia.CompletedNCT00034775Phase 3
- The Efficacy and Safety of Risperidone in the Treatment of Adolescents With SchizophreniaCompletedNCT00034749Phase 3
- PET Scanning in Parkinson s DiseaseCompletedNCT00024622
- 5HT3 Antagonism and Auditory Gating in SchizophreniaCompletedNCT00018850Not applicable
- Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment OutcomeCompletedNCT00018837Not applicable
- Antipsychotic Response in SchizophreniaCompletedNCT00018668Phase 4
- Quetiapine vs Haloperidol Decanoate for the Long Term Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00018642Not applicable
- Cognitive - Behavioral TherapyCompletedNCT00018629Phase 2
- CATIE- Schizophrenia TrialCompletedNCT00014001Phase 4
- A Multi-Site Study of Strategies for Implementing Schizophrenia GuidelinesCompletedNCT00013000Not applicable
- Improving Health Services for Veterans With SchizophreniaCompletedNCT00012961
- To Determine if Olanzapine is More Cost Effective Than Haloperidol for the Treatment of SchizophreniaCompletedNCT00007774Phase 4
- Molecular Genetics of SchizophreniaCompletedNCT00006418
- Glucose Regulation During Risperidone and Olanzapine TreatmentStatus unknownNCT00006195Not applicable
- Glycine to Treat Psychotic Disorders in ChildrenCompletedNCT00005658Phase 2
- Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy VolunteersCompletedNCT00004571
- Electrophysiology and Blood Flow in Patients With Schizophrenia and Their SiblingsCompletedNCT00001921
- Eye Blink Response in Healthy Volunteers and Adults With SchizophreniaCompletedNCT00001920
- I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal VolunteersCompletedNCT00001771
- Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)CompletedNCT00001768Phase 3
- Genetic Aspects of Neurologic and Psychiatric DisordersCompletedNCT00001544
- Genetic Study of SchizophreniaCompletedNCT00001486
- Neuropsychiatric Evaluation of Healthy Volunteers and Adults With SchizophreniaCompletedNCT00001323
- Neuroimaging of Dopamine Metabolism in Normal and Psychiatric PatientsCompletedNCT00001320
- Brain Tissue Collection for Neuropathological StudiesTerminatedNCT00001260
- Studies of Frontal Lobe Brain Functioning in SchizophreniaCompletedNCT00001258
- Inpatient Evaluation of Adults With SchizophreniaCompletedNCT00001247
- Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy VolunteersCompletedNCT00001246
- Evaluating Genetic Risk Factors for Childhood-Onset SchizophreniaTerminatedNCT00001198
- Neuropsychological Evaluation of Psychiatric and Neurological PatientsCompletedNCT00001192
- Self-Management Therapy for Youth With SchizophreniaCompletedNCT00000387Phase 3
- Treatment for First-Episode SchizophreniaCompletedNCT00000374Phase 4
- Glycine and D-Cycloserine in SchizophreniaWithdrawnNCT00000372Phase 3